Lower risk Drug recall · FDA · Published June 23, 2026

Lupin Glucagon Emergency Kit Recall: CGMP Deviation Risk

Lupin Pharmaceuticals recalls Glucagon Emergency Kits due to a CGMP deviation in stability testing. Affected kits have specific lot numbers and expiration dates. Consumers should contact the manufacturer for details.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-0723-2026Drug Lupin ›

Lower-risk recall

CGMP deviation: OOS result observed for the Gliding Force functionality test during 12-month long term stability testing.

Take action

Contact the company

Recalling firmLupin Pharmaceuticals Inc.5801 Pelican Bay Blvd Ste 500 · Naples, FL 34108-2734

✎ GovInfoNow plain-language explainer

Lupin Pharmaceuticals is recalling Glucagon Emergency Kits for low blood sugar treatment due to a manufacturing issue found during stability testing. This could affect the kit's reliability in emergencies, so affected users should check their lot numbers and contact Lupin for guidance. Read more at govinfonow.com/recall/31192-lupin-glucagon-emergency-kit-recall-cgmp-deviation-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/31192-lupin-glucagon-emergency-kit-recall-cgmp-deviation-risk · Updated August 9, 2026 · FDA enforcement record: FDA #D-0723-2026

Cite this page

“Lupin Glucagon Emergency Kit Recall: CGMP Deviation Risk.” GovInfoNow, updated August 9, 2026. https://govinfonow.com/recall/31192-lupin-glucagon-emergency-kit-recall-cgmp-deviation-risk. Based on FDA recall #D-0723-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0723-2026%22&limit=1).

The FDA announced on June 23, 2026, that Lupin Pharmaceuticals Inc. is recalling Glucagon Emergency Kits due to a CGMP deviation involving out-of-specification gliding force results. The recall affects 64,894 units distributed nationwide.

How to tell if you have it

Brand: Lupin
Product: Glucagon Emergency Kit for Low Blood Sugar, Glucagon for Injection USP, 1mg per vial, Diluent for Glucagon, 1 mL syringe
NDC: 70748-311-01
Lot Codes: WB00010 (Exp. Jan 2027), WB00017/WB00019 (Exp. Feb 2027), WB00070 (Exp. Jun 2027), WB00077/WB00078 (Exp. Jul 2027), WB00130 (Exp. Nov 2027)

The hazard

The recall is due to a CGMP deviation where an out-of-specification result was observed for the gliding force functionality test during 12-month long-term stability testing.

Context

GovInfoNow's records show Lupin Pharmaceuticals Inc. has 90 other recalls on record since January 31, 2013. Other recent recalls of similar products include Lupin Clobetasol Cream Recall (August 3, 2026), Lupin prednisolone acetate ophthalmic suspension recall (June 4, 2026), and Lupin Liraglutide 18mg/3mL Injection Recall (April 24, 2026). Other recent recalls of similar products include Nivagen Zinc Oxide Ointment Recall (October 31, 2025) and Wells Pharma Fentanyl Citrate Recall (April 1, 2026).

How to tell if you have this one

Check the kit's lot number on the packaging. Affected lots include WB00010 (exp. Jan 2027), WB00017, WB00019 (exp. Feb 2027), WB00070 (exp. Jun 2027), WB00077, WB00078 (exp. Jul 2027), and WB00130 (exp. Nov 2027).

Brand
Lupin
Category
Drug

Based on the official FDA remedy

What to do — step by step

Check Kit Lot Number
Look for the lot number on the packaging to determine if it is one of the affected lots listed in the recall.

Where it went and when

Where it was distributed

Distributed nationwide.

FDA distribution: “Nationwide within the U.S.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 15 days after the firm started it.

Jun 23, 2026Firm started the recall
Jul 8, 2026Published in FDA’s Enforcement Report
Jul 23, 2026FDA classified it Class II

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

From the GovInfoNow team · based on the FDA notice · How we make summaries

Is there a risk of serious injury?

The recall indicates a potential reliability issue, but no specific injury risk is mentioned in the official notice.

Similar recalls

Other Lupin recalls

Latest drug recalls

Keep exploring

Link to this recall

<a href="https://govinfonow.com/recall/31192-lupin-glucagon-emergency-kit-recall-cgmp-deviation-risk">Lupin Glucagon Emergency Kit Recall: CGMP Deviation Risk (GovInfoNow)</a>

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #D-0723-2026 (June 23, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0723-2026 to see it in context.
Plain-language summary written by qwen3:4b on August 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.